mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Predicted mutations | |||||||
|---|---|---|---|---|---|---|---|
| evidence | seq id | position | mutation | freq | annotation | gene | description |
| RA | CP000731 | 81 | N→G | 100% | intergenic (–/‑151) | – / → repA | –/replication protein A |
| JC | CP000731 | 6,552 | +28 bp | 100% | intergenic (+1069/‑419) | cadX → / → USA300HOU_pUSA300HOUMR0010 | cadmium efflux regulator/MarR family transcriptional regulator |
| RA | CP000731 | 25,663 | Δ1 bp | 100% | coding (316/333 nt) | USA300HOU_pUSA300HOUMR0031 → | hypothetical protein |
| JC | USA300TCH1516_ALE | 62,817 | +TCAATT | 100% | intergenic (‑284/+229) | USA300TCH1516_00053 ← / ← speG | hypothetical protein/Spermidine N(1)‑acetyltransferase |
| RA | USA300TCH1516_ALE | 111,512 | A→G | 28.5% | S194S (TCA→TCG) | USA300HOU_RS00520 → | putative lipoprotein |
| RA | USA300TCH1516_ALE | 111,516 | C→A | 28.5% | Q196K (CAA→AAA) | USA300HOU_RS00520 → | putative lipoprotein |
| RA | USA300TCH1516_ALE | 512,643 | A→G | 16.6% | intergenic (+711/‑6052) | recR → / → speA_2 | Recombination protein RecR/Arginine decarboxylase |
| RA | USA300TCH1516_ALE | 611,156 | T→A | 10.0% | G155G (GGT→GGA) | azo1 → | FMN‑dependent NADPH‑azoreductase |
| RA | USA300TCH1516_ALE | 622,464 | G→A | 22.7% | S1009S (TCG→TCA) | sdrE → | Serine‑aspartate repeat‑containing protein E |
| RA | USA300TCH1516_ALE | 1,416,458 | A→T | 100% | I216N (ATT→AAT) | oppD_4 ← | Oligopeptide transport ATP‑binding protein OppD |
| RA | USA300TCH1516_ALE | 1,513,930 | A→T | 100% | L413F (TTA→TTT) | USA300HOU_RS07375 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 1,562,781 | T→C | 9.4% | P366P (CCA→CCG) | lytN_2 ← | putative cell wall hydrolase LytN |
| RA | USA300TCH1516_ALE | 1,614,185 | T→C | 15.4% | D129D (GAT→GAC) | USA300HOU_RS08000 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 1,616,078 | G→T | 10.5% | P113Q (CCA→CAA) | nudF ← | ADP‑ribose pyrophosphatase |
| RA | USA300TCH1516_ALE | 1,643,957 | C→T | 56.5% | A38A (GCG→GCA) | cfiB_2 ← | 2‑oxoglutarate carboxylase small subunit |
| RA | USA300TCH1516_ALE | 1,646,189 | G→C | 100% | A155G (GCA→GGA) | ypdF ← | Aminopeptidase YpdF |
| RA | USA300TCH1516_ALE | 1,744,428 | T→C | 16.5% | K82E (AAA→GAA) | apt ← | Adenine phosphoribosyltransferase |
| RA | USA300TCH1516_ALE | 1,744,450 | A→T | 32.1% | F74L (TTT→TTA) | apt ← | Adenine phosphoribosyltransferase |
| RA | USA300TCH1516_ALE | 2,010,363 | C→T | 100% | C146Y (TGT→TAT) | USA300HOU_RS10125 ← | Putative multidrug export ATP‑binding/permease protein |
| RA | USA300TCH1516_ALE | 2,219,234 | C→T | 9.1% | A258T (GCA→ACA) | murA1 ← | UDP‑N‑acetylglucosamine 1‑carboxyvinyltransferase 1 |
| RA | USA300TCH1516_ALE | 2,279,705 | G→A | 100% | A943V (GCA→GTA) | ebh_3 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 2,532,298 | A→T | 100% | T15T (ACA→ACT) | femA_3 → | Aminoacyltransferase FemA |
| RA | USA300TCH1516_ALE | 2,541,351 | A→G | 9.5% | L307L (TTA→TTG) | sbi → | Immunoglobulin‑binding protein sbi |